Recurrent Low-Grade Glioma
general11
Centers
6
Active Trials
$4.8B
Cancer Funding
Specific Cancer Types(1)
| Name | Centers |
|---|---|
| Recurrent WHO Grade II Glioma | 11 |
Top Centers for Recurrent Low-Grade Glioma(11)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | NCI Comprehensive High-Volume Research Center | 100.0 |
| 2 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | — |
| 3 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive | — |
| 4 | NCI Comprehensive | — |
| 5 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive | — |
| 6 | Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive | — |
| 7 | Duke Cancer InstituteDurham, NC NCI Comprehensive | — |
| 8 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive | — |
| 9 | NCI Clinical | — |
| 10 | Cleveland Clinic Cancer CenterCleveland, OH | — |
| 11 | Boston University Cancer CenterBoston, MA | — |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →